DALLAS--(BUSINESS WIRE)--Colossal Biosciences (“Colossal”), the world’s first de-extinction company, announces today that their Woolly Mammoth team has achieved a global-first iPSC (induced ...
Scientists have made a leap in genetic engineering by pushing elephant cells into an embryonic-like state. This marks a major step toward recreating traits of the extinct woolly mammoth, offering new ...
When the elevator doors part on the second floor of a two-story brick and glass building in an office park on the outskirts of downtown Dallas, it feels like a portal opening to a different world. The ...
There are an estimated 1.5 million genetic differences between woolly mammoths and Asian elephants. Colossal Biosciences, the ...
The start-up Colossal Biosciences aims to use gene-editing technology to bring back the woolly mammoth and other extinct species. Recently, the company achieved major milestones: last year, they ...
Forbes contributors publish independent expert analyses and insights. I write about biodiversity and the hidden quirks of the natural world. Colossal Biosciences is now valued at over $10 billion and ...
Colossal Biosciences CEO Ben Lamm speaking at SXSW in Austin, Texas on March 9. Amy E. Price/SXSW Conference & Festivals via Getty Images The biotech aspect, which involves genetically engineering ...